Literature DB >> 26923774

Letter to the editor: Is there a need for special treatment of refugees at hospital admission?

Jan Walter1, Sebastian Haller, Julia Hermes, Mardjan Arvand, Muna Abu Sin, Tim Eckmanns.   

Abstract

Keywords:  Antimicrobial resistance; Germany; Surveillance; isolation; migration; screening

Mesh:

Substances:

Year:  2016        PMID: 26923774     DOI: 10.2807/1560-7917.ES.2016.21.7.30137

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


× No keyword cloud information.
  5 in total

1.  [Urological infections and migration].

Authors:  K Bausch; E Kulchavenya; F Wagenlehner; G Bonkat
Journal:  Urologe A       Date:  2019-10       Impact factor: 0.639

2.  High prevalence of MRSA and multi-resistant gram-negative bacteria in refugees admitted to the hospital-But no hint of transmission.

Authors:  Annelene Kossow; Bianca Stühmer; Frieder Schaumburg; Karsten Becker; Birgit Glatz; Mareike Möllers; Stefanie Kampmeier; Alexander Mellmann
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

3.  No evidence of carbapenemase-producing Enterobacteriaceae in stool samples of 1,544 asylum seekers arriving in Rhineland-Palatinate, Germany, April 2016 to March, 2017.

Authors:  Lutz Ehlkes; Yvonne Pfeifer; Guido Werner; Ralf Ignatius; Manfred Vogt; Tim Eckmanns; Philipp Zanger; Jan Walter
Journal:  Euro Surveill       Date:  2019-02

4.  Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals.

Authors:  Ursel Heudorf; Sabine Albert-Braun; Klaus-Peter Hunfeld; Franz-Ulrich Birne; Jörg Schulze; Klaus Strobel; Knut Petscheleit; Volkhard A J Kempf; Christian Brandt
Journal:  GMS Hyg Infect Control       Date:  2016-08-09

5.  Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.

Authors:  Laura B Nellums; Hayley Thompson; Alison Holmes; Enrique Castro-Sánchez; Jonathan A Otter; Marie Norredam; Jon S Friedland; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2018-05-17       Impact factor: 71.421

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.